Предыдущая публикация
Global Urology Surgical Instrument Market 2023 Growth Forecast Analysis by Demand, Manufacturers, Regions, Type and Application.
Download Free Sample Copy of Report@ http://bit.ly/2RQlbE5 The market is majorly being driven by increasing prevalence of urinary tract infections (UTIs) in women, surging geriatric population, and rising prevalence of benign prostatic hyperplasia (BPH) procedures.
On the basis of product, the market has been categorized into consumables and accessories, urology endoscopes, endovision systems, and peripheral instruments. The consumables and accessories category is predicted to lead the urology surgical instrument market, both in terms of size and growth. The category contributed a 45.3% share in the global market in 2017 and is expected to progress at a CAGR of 9.1% during the forecast period. This leading position is mainly attributable to the high use of guidewires, stone basket, stents, catheters and dilator sets in urology surgery.
Asia-Pacific (APAC) is expected to be the fastest growing urology surgical instrument market during the forecast period, with a CAGR of 9.4%. This can be attributed to increasing awareness about urological disorders, leading medical tourism destinations, and growing healthcare industry in the region.
Globally, key players in the urology surgical instrument industry are acquiring other firms to attain a higher position in the market. For instance, in March 2018, Boston Scientific Corporation announced that it acquired EMcision Limited, a developer of medical devices in the U.K. and Canada. The acquisition would expand the Boston Scientific Endoscopy portfolio to include the HabibTM EndoHPB probe, a novel endoscopic bipolar radiofrequency device, which coagulates tissue in the gastrointestinal (GI) tract.
Следующая публикация
Нет комментариев